Because our results show that CD4+ T cells from a mouse model of allergy could still differentiate into Tregs under appropriate conditions of limited IL-4 and IFN-γ production, we consider that regulation of the cytokines may be useful for designing treatments using iTregs. The gene discussed is IFNG; the disease is Allergy.